Every S-3 that Cosmos Holdings Inc. (COSM) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-3 covers the shelf registration that lets an established company sell over time, so if you follow COSM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COSM filings page.
Cosmos Health Inc. amends its Form S-3 shelf registration to update the prospectus and risk disclosures and to reflect SEC staff comments; no new securities are being registered. The shelf permits offers of up to $200,000,000 of Common Stock, Preferred Stock, Warrants, Units and Subscription Rights to be sold from time to time. The prospectus states 62,078,397 shares of Common Stock were outstanding as of June 3, 2026, with 47,099,220 held by non-affiliates; the recent filing notes an available remaining resale capacity of $3,639,060 under a prior prospectus supplement.
The filing discloses a digital assets treasury strategy tied to a Securities Purchase Agreement with ATW Digital Asset Opportunities VII LLC that contemplates notes up to an aggregate $300,000,000 facility; an initial $8.0 million note was issued in August 2025 (approximately $3.1 million of those net proceeds were used to acquire crypto and $1.8 million for working capital). The prospectus highlights material risks from concentrating assets in crypto (price volatility, custodial and regulatory risks) and states the company may stake ETH and hold crypto as a balance-sheet treasury asset.
Cosmos Health Inc. filed an amended registration statement to register 73,523,716 shares of Common Stock for resale by selling stockholders, consisting of 67,045,455 shares potentially issuable under the August 2025 Note and the Second Note and 6,478,261 shares potentially issuable under the June 2025 Note. The registration is based on maximum potential conversion at a $0.176 conversion/floor price and assumes notes and in-kind interest remain outstanding until maturity.
As of April 23, 2026, the company reported 52,617,105 shares issued and outstanding; the prospectus shows a pro forma post-offering figure of 126,054,324 shares. The Selling Stockholders will receive proceeds from resale; the company will not receive proceeds from these sales. The prospectus also discloses the company’s recently adopted digital assets treasury strategy, including prior purchases of Ethereum and Bitcoin, custodial arrangements with BitGo Prime LLC, engagement of Prime Ledger LLC, and staking plans, and highlights substantial risks, going concern disclosures, and applicable accounting (ASU 2023-08).
Cosmos Health Inc. filed a replacement Form S-3 shelf registering up to $200,000,000 of common stock, preferred stock, warrants, units and subscription rights to be offered from time to time after effectiveness. The filing also includes a prospectus supplement for an at-the-market offering of up to $100,000,000 of common stock through A.G.P., which will earn a 3% commission on gross proceeds.
The company notes that, as of November 6, 2025, 34,919,920 shares of common stock were outstanding, with 26,274,546 held by non‑affiliates. Our common stock last closed at $0.67 on November 6, 2025, and trades on Nasdaq as “COSM.”
Unless otherwise indicated in a supplement, net proceeds are intended for the acquisition of crypto assets as a treasury asset and for general corporate purposes and working capital. Sales under the ATM may occur at market prices “from time to time,” subject to Securities Act Rule 415 and public float constraints.